Former IBM Watson Health sales executive, Bill Hutchins, is joining Deep 6 AI to support the rapid expansion of its clinical trial patient recruitment platform across hospitals, pharmaceutical companies and contract research organizations. Hutchins previously served as IBM Watson for Oncology Sales Director – Western US where he was focused on clinical trial matching, oncology and genomics.
According to Hutchins, “I’m very excited to join the Deep 6 AI team. When I first saw the software, I immediately realized that both Deep 6 AI’s product and business model are easily the best on the market today. Deep 6’s seamless combination of cutting-edge AI techniques and intuitive user workflows, designed with extensive input from researchers and patient recruitment specialists, puts us lightyears ahead of competitors. I look forward to being able to provide clients with a comprehensive patient recruitment solution for all of their trials, regardless of disease type.”
Hutchins brings more than 15 years of healthcare expertise in developing strategic partnerships with academic medical centers, hospitals, government health institutes, IDNs and medical groups. His experience includes providing artificial intelligence and natural language processing-based solutions for clinical trial matching, clinical care improvement, revenue cycle management and electronic health record analysis. Prior to IBM Watson Health, Hutchins worked in sales leadership roles with athenahealth, Alere Analytics, TherapyLogix, Cedaron Medical and BMS Practice Solutions.
“We are thrilled to have Bill join our team,” said Wout Brusselaers, CEO of Deep 6 AI. “With strong interest from health systems, sponsors and CROs, fueled by the enthusiastic feedback from our existing users, it was time to bring on strategic business development experts to help us expand. Bill brings not just targeted expertise selling artificial intelligence solutions for clinical trial patient recruitment, but he also truly appreciates the importance of developing long-term relationships with our customers.”
About Deep 6 AI
Using artificial intelligence on medical records, Deep 6 AI finds more, better-matching patients for clinical trials in minutes, not months, getting life-saving cures to patients more quickly. Deep 6 AI also helps sponsors and CROs with better trial feasibility design, site selection, real-time analysis of study results, and improved trial response rates from selecting better-matching trial subjects. Deep 6 AI is a Techstars, StartX and Healthbox alum and is currently in use by leading hospitals, such as Cedars-Sinai Medical Center, research institutes and CROs. The company was founded in 2015 and is based in Pasadena, CA. Learn more at https://deep6.ai.
Information contained on this page is provided by an independent third-party content provider. This Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact support [at] perpetualwire.com.